Sort
172,184 grants matching “inflammation”
Nicotinamide Adenine Dinucleotide Augmentation to Prevent or Reverse the Progression of Alzheimer's Disease in People with Down Syndrome
$801,359Shalendar Bhasin · Brigham And Women'S Hospital · R01 · FY2025 · AG
Targeting cerebrovascular Wnt/beta-catenin signaling to reverse brain endothelial damage induced by SARS-CoV-2 infection
$801,329Sarah Elizabeth Lutz · University Of Illinois At Chicago · R01 · FY2025 · NS
Facility and Web-based Approaches to Lifestyle Change in Resistant Hypertension
$801,271James A. Blumenthal · Duke University · R01 · FY2015 · HL
VISTA is a negative checkpoint regulator of innate immunity
$801,269Randolph J. Noelle · Dartmouth College · R01 · FY2022 · AI
Role of TLR4-lipid rafts in nociception
$801,239Tony L Yaksh · University Of California, San Diego · R01 · FY2024 · NS
DISCOVERY CENTER FOR INNATE IMMUNITY PGA
$801,170University Of Arizona · U01 · FY2002 · HL
Pathogenesis of Obstruction/Emphysema and the Microbiome (POEM) in HIV
$801,166Alison Morris · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · HL
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function
$801,159Amil M Shah · Brigham And Women'S Hospital · R01 · FY2019 · HL
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
$801,143Robert D. Burk · Albert Einstein College Of Medicine · R01 · FY2024 · DE
ABCB5-positive stem cells for LSCD therapy
$801,142Markus H. Frank · Boston Children'S Hospital · R01 · FY2023 · EY
Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death
$801,056Zian H Tseng · University Of California, San Francisco · R01 · FY2022 · HL
Protection against early SIV brain injury with adjunctive therapy to cART
$801,050Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2024 · NS
Hispanics, built environment & metabolic syndrome
$801,039Jose Szapocznik · University Of Miami School Of Medicine · R01 · FY2010 · DK
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies
$801,031Deanna L Kelly · University Of Maryland Baltimore · R01 · FY2017 · MH
Administrative
$801,025David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2018 · AI
Depression, Estrogen Replacement, and Cardiovascular Health in the Perimenopause
$801,004Susan S. Girdler · Univ Of North Carolina Chapel Hill · R01 · FY2010 · MH
The Impacts of Adverse Provider Conditions on Provider Bias and Health Disparities
$800,983Anastasia Makhanova · University Of Arkansas At Fayetteville · R01 · FY2024 · MD
Endothelial Inflammation, Src Kinase Dysregulation, and Fibrosis in Early Pulmonary Arterial Hypertension
$800,962Bradley Wertheim · Brigham And Women'S Hospital · R01 · FY2025 · HL
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2022 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2019 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2021 · NS
Validation of Modulators of PGRN as Novel Therapeutics for Frontotemporal Dementi
$800,931Joachim J Herz · Ut Southwestern Medical Center · R01 · FY2020 · NS
Social integration, daily social interaction, and health risk pathways in midlife
$800,923Thomas W Kamarck · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AG
Structural Racism and Discrimination in Older Men's Health Inequities
$800,878Jesus Ramirez-Valles · University Of California, San Francisco · R01 · FY2024 · AG
Training in Translational Lung Biology and Pathobiology
$800,827Naftali Kaminski · Yale University · T32 · FY2020 · HL